Literature DB >> 10992547

A new class of lipid mediators: cytochrome P450 arachidonate metabolites.

M A Carroll1, J C McGiff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10992547      PMCID： PMC1765956          DOI： 10.1136/thorax.55.suppl_2.s13

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  41 in total

1.  Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways.

Authors:  J D Imig; P C Deichmann
Journal:  Am J Physiol       Date:  1997-08

2.  Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole.

Authors:  S Arima; Y Endo; H Yaoita; K Omata; S Ogawa; K Tsunoda; M Abe; K Takeuchi; K Abe; S Ito
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 3.  Hyperpolarizing factors.

Authors:  J Quilley; D Fulton; J C McGiff
Journal:  Biochem Pharmacol       Date:  1997-11-15       Impact factor: 5.858

4.  Cytochrome P450-derived renal HETEs: storage and release.

Authors:  M A Carroll; M Balazy; D D Huang; S Rybalova; J R Falck; J C McGiff
Journal:  Kidney Int       Date:  1997-06       Impact factor: 10.612

5.  Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors.

Authors:  M H Wang; E Brand-Schieber; B A Zand; X Nguyen; J R Falck; N Balu; M L Schwartzman
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

6.  Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa.

Authors:  W J Welch; C S Wilcox
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

7.  Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.

Authors:  O G Khatsenko; S S Gross; A B Rifkind; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles.

Authors:  C W Sun; M Alonso-Galicia; M R Taheri; J R Falck; D R Harder; R J Roman
Journal:  Circ Res       Date:  1998-11-30       Impact factor: 17.367

9.  Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading.

Authors:  J H Capdevila; S Wei; J Yan; A Karara; H R Jacobson; J R Falck; F P Guengerich; R N DuBois
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

10.  Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart.

Authors:  D Fulton; J C Mcgiff; J Quilley
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030
View more
  12 in total

Review 1.  Genetic associations with hypertension: meta-analyses of six candidate genetic variants.

Authors:  Cheng Zhang; Lingyan Wang; Qi Liao; Lina Zhang; Leiting Xu; Cheng Chen; Huadan Ye; Xuting Xu; Meng Ye; Shiwei Duan
Journal:  Genet Test Mol Biomarkers       Date:  2013-07-16

2.  Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.

Authors:  In-Hae Kim; Kosuke Nishi; Hsing-Ju Tsai; Tanya Bradford; Yasuko Koda; Takaho Watanabe; Christophe Morisseau; Joanne Blanchfield; Istvan Toth; Bruce D Hammock
Journal:  Bioorg Med Chem       Date:  2006-09-29       Impact factor: 3.641

3.  Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.

Authors:  In-Hae Kim; Fenton R Heirtzler; Christophe Morisseau; Kosuke Nishi; Hsing-Ju Tsai; Bruce D Hammock
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

Review 4.  Rationally designed multitarget agents against inflammation and pain.

Authors:  S H Hwang; A T Wecksler; K Wagner; B D Hammock
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation.

Authors:  Bahar Tunctan; Belma Korkmaz; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; Mehmet Sami Serin; C Kemal Buharalioglu; Seyhan Sahan-Firat; Tuba Cuez; Wolf-Hagen Schunck; John R Falck; Kafait U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-02-27       Impact factor: 3.072

6.  Association of a CYP4A11 variant and blood pressure in black men.

Authors:  James V Gainer; Michael S Lipkowitz; Chang Yu; Michael R Waterman; Elliott P Dawson; Jorge H Capdevila; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

7.  1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.

Authors:  In-Hae Kim; Hsing-Ju Tsai; Kosuke Nishi; Takeo Kasagami; Christophe Morisseau; Bruce D Hammock
Journal:  J Med Chem       Date:  2007-09-26       Impact factor: 7.446

8.  Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.

Authors:  Christelle Tesson; Magdalena Nawara; Mustafa A M Salih; Rodrigue Rossignol; Maha S Zaki; Mohammed Al Balwi; Rebecca Schule; Cyril Mignot; Emilie Obre; Ahmed Bouhouche; Filippo M Santorelli; Christelle M Durand; Andrés Caballero Oteyza; Khalid H El-Hachimi; Abdulmajeed Al Drees; Naima Bouslam; Foudil Lamari; Salah A Elmalik; Mohammad M Kabiraj; Mohammed Z Seidahmed; Typhaine Esteves; Marion Gaussen; Marie-Lorraine Monin; Gabor Gyapay; Doris Lechner; Michael Gonzalez; Christel Depienne; Fanny Mochel; Julie Lavie; Ludger Schols; Didier Lacombe; Mohamed Yahyaoui; Ibrahim Al Abdulkareem; Stephan Zuchner; Atsushi Yamashita; Ali Benomar; Cyril Goizet; Alexandra Durr; Joseph G Gleeson; Frederic Darios; Alexis Brice; Giovanni Stevanin
Journal:  Am J Hum Genet       Date:  2012-11-21       Impact factor: 11.025

Review 9.  Arachidonic acid metabolites in pathogenic yeasts.

Authors:  Ruan Ells; Johan Lf Kock; Jacobus Albertyn; Carolina H Pohl
Journal:  Lipids Health Dis       Date:  2012-08-08       Impact factor: 3.876

10.  CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.

Authors:  C C White; Q Feng; L A Cupples; J V Gainer; E P Dawson; R A Wilke; N J Brown
Journal:  Pharmacogenomics J       Date:  2011-09-13       Impact factor: 3.550
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.